pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F

被引:0
|
作者
Yat Peng Chew
Mark Ellis
Scott Wilkie
Sibylle Mittnacht
机构
[1] Institute of Cancer Research,
[2] Chester Beatty Laboratory,undefined
来源
Oncogene | 1998年 / 17卷
关键词
retinoblastoma protein; pRB; E2F; phosphorylation; checkpoint control; cell cycle;
D O I
暂无
中图分类号
学科分类号
摘要
Progression of cells into S phase is controlled by the retinoblastoma protein (pRB) and relies on the functional inactivation of this tumour suppressor in late G1 via protein phosphorylation. We provide evidence here that, besides controlling entry of cells into S phase, pRB can operate to inhibit S phase completion. Differential arrays of phosphorylation appear to regulate these different events, suggesting that cycle progression at these two stages of the cell cycle may be achieved via activation of distinct downstream pRB effector pathways. In agreement with this hypothesis, pRB's ability to prevent S phase entry, but not its ability to inhibit S phase completion, correlates with repression of E2F-regulated promoters. Furthermore, ectopic expression of E2F or the E2F-regulated cyclin E gene promote S phase entry in cells expressing phosphorylation-defective pRB but neither is sufficient to trigger completion of S phase. Our findings raise the possibility that pRB, in addition to its well-established role in controlling a checkpoint in late G1, could be involved in the control of a further checkpoint operating during S phase and that implementation of this checkpoint relies on an as yet unidentified pRB effector distinct from E2F.
引用
收藏
页码:2177 / 2186
页数:9
相关论文
共 50 条
  • [31] Phosphorylation of pRB at Ser612 by Chk1/2 leads to a complex between pRB and E2F-1 after DNA damage
    Inoue, Yasumichi
    Kitagawa, Masatoshi
    Taya, Yoichi
    EMBO JOURNAL, 2007, 26 (08): : 2083 - 2093
  • [32] Regulation in S phase by E2F
    Pardee, AB
    Li, CJ
    Reddy, GPV
    CELL CYCLE, 2004, 3 (09) : 1091 - 1094
  • [33] THE PRB-RELATED PROTEIN P107 CONTAINS 2 GROWTH SUPPRESSION DOMAINS - INDEPENDENT INTERACTIONS WITH E2F AND CYCLIN CDK COMPLEXES
    ZHU, L
    ENDERS, G
    LEES, JA
    BEIJERSBERGEN, RL
    BERNARDS, R
    HARLOW, E
    EMBO JOURNAL, 1995, 14 (09): : 1904 - 1913
  • [34] Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate
    Ahmad, N
    Adhami, VM
    Gupta, S
    Cheng, PY
    Mukhtar, H
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 398 (01) : 125 - 131
  • [35] Study of pRb and E2F transcription factor expression in normal and leukemic cells using flow cytometry.
    Delbrel, X
    Ferry-Dumazet, H
    Dupouy, M
    Villard, JF
    Reiffers, J
    Lacombe, F
    BLOOD, 1998, 92 (10) : 163B - 163B
  • [36] Regulation of E2F through ubiquitin-proteasome-dependent degradation: Stabilization by the pRB tumor suppressor protein
    Campanero, MR
    Flemington, EK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2221 - 2226
  • [37] 4-hydroxynonenal affects pRb/E2F pathway in HL-60 human leukemic cells
    Barrera, G
    Pizzimenti, S
    Laurora, S
    Moroni, E
    Giglioni, B
    Dianzani, MU
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 295 (02) : 267 - 275
  • [38] Conservation of plant and mammalian G1/S controls: Interaction of plant D type cyclins with pRb and mammalian E2F
    Huntley, RP
    Freeman, DR
    deJager, S
    Healy, JMS
    Murray, JAH
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 81 - 81
  • [39] Differentiation and injury-repair signals modulate the interaction of E2F and pRB proteins with novel target genes in keratinocytes
    Chang, Wing Y.
    Andrews, Joseph
    Carter, David E.
    Dagnino, Lina
    CELL CYCLE, 2006, 5 (16) : 1872 - 1879
  • [40] Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis
    T Parisi
    R T Bronson
    J A Lees
    Oncogene, 2009, 28 : 500 - 508